China Cord Blood Corp  

(Public, NYSE:CO)   Watch this stock  
Find more results for CO
6.33
-0.19 (-2.91%)
Sep 2 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 6.30 - 6.55
52 week 4.10 - 7.69
Open 6.55
Vol / Avg. 59,571.00/313,667.00
Mkt cap 523.21M
P/E 29.65
Div/yield     -
EPS 0.21
Shares 80.08M
Beta 0.69
Inst. own 27%
Nov 23, 2015
Q2 2016 China Cord Blood Corp Earnings Release (Estimated) Add to calendar
Aug 20, 2015
Q1 2016 China Cord Blood Corp Earnings Call
Aug 19, 2015
Q1 2016 China Cord Blood Corp Earnings Release
Jun 19, 2015
Q4 2015 China Cord Blood Corp Earnings Call - Webcast
Jun 18, 2015
Q4 2015 China Cord Blood Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2015
Net profit margin 10.64% 16.97%
Operating margin 30.38% 37.00%
EBITD margin - 44.97%
Return on average assets 1.72% 2.78%
Return on average equity 2.33% 6.67%
Employees 1,039 -
CDP Score - -

Address

48th Floor, Bank of China Tower 1 Garden Road, Central
,
Hong Kong
+85236058180 (Phone)
+85236058181 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

China Cord Blood Corporation (CCBC) is a provider of cord blood storage and ancillary services. The Company is engaged in the provision of umbilical cord blood storage and ancillary services in its cord blood banks in the People’s Republic of China (PRC). The Company provides cord blood storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants. It also tests; processes and stores donated cord blood, and provides matching services to the public.

Officers and directors

Yuen Kam Chairman of the Board
Age: 52
Bio & Compensation  - Reuters
Ting Zheng Chief Executive Officer, Director
Age: 42
Bio & Compensation  - Reuters
Albert Chen Chief Financial Officer, Director
Age: 38
Bio & Compensation  - Reuters
Rui Arashiyama Chief Executive Officer - Guangdong and Zhejiang Divisions
Age: 55
Bio & Compensation  - Reuters
Yue Deng Chief Executive Officer - Beijing Division
Age: 44
Bio & Compensation  - Reuters
Xin Xu Chief Technology Officer
Age: 60
Bio & Compensation  - Reuters
Mark D. Chen Independent Non-Executive Director
Age: 46
Bio & Compensation  - Reuters
Ken Lu Independent Non-Executive Director
Age: 50
Bio & Compensation  - Reuters
Jennifer J. Weng Independent Non-Executive Director
Age: 46
Bio & Compensation  - Reuters